Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Smoldering Multiple Myeloma 3Monoclonal Gammopathy of Undetermined Significance 3Stomach Neoplasms 2Prostatic Neoplasms 2Multiple Myeloma 2Uterine Cervical Dysplasia 1Thrombocythemia, Essential 1Rectal Neoplasms 1Psychological Well-Being 1Primary Myelofibrosis 1Polycythemia Vera 1Polycystic Ovary Syndrome 1Neurofibromatosis 1 1Neoplasms 1Myelodysplastic Syndromes 1Motor Activity 1Lung Neoplasms 1Joint Diseases 1Gastritis, Atrophic 1Esophageal Neoplasms 1Colonic Neoplasms 1Castration Sensitive Prostate Cancer 1Breast Neoplasms 1Arthralgia 1

Interventions

Oxaliplatin 27Fluorouracil 23Leucovorin 22Cetuximab 22Bevacizumab 21Nivolumab 16Capecitabine 16Irinotecan 15pembrolizumab 12Magnetic Resonance Spectroscopy 11Specimen Handling 10encorafenib 8Folfox protocol 7trifluridine tipiracil drug combination 6Ipilimumab 6Exercise 6fludarabine 5cemiplimab 5Trastuzumab 5Gemcitabine 5Cyclophosphamide 5Cisplatin 5Blood Specimen Collection 5Biopsy 5regorafenib 4pertuzumab 4adagrasib 4Trifluridine 4Surgical Procedures, Operative 4Pemetrexed 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colonic Neoplasms × Curcumin × 1 year × Clear all
NCT02724202 2026-02-06

Curcumin in Combination With 5FU for Colon Cancer

Baylor Research Institute

Phase EARLY_PHASE1 Terminated
15 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡